期刊文献+

Technical challenges in tackling regulatory concerns for urban atmospheric nanoparticles 被引量:3

原文传递
导出
摘要 Recent Euro 5 and Euro 6 vehicle emission standards are the first ever initiative to control particles on a number basis at the source. Related standards are also desirable for ambient nanoparticles (taken in this article to be those below 300 rim) to protect against possible adverse effects on public health and the environment. However, there are a number of technical challenges that need to be tackled before developing a regulatory framework for atmospheric nanoparticles. Some of the challenges derive from a lack of standardisation of the key measurement parameters, including sampling, necessary for robust evaluation of particle number concentrations, especially in the context of insufficient knowledge of the physicochemical characteristics of emerging sources (i.e. bio-fuel derived and manufactured nanoparti- cles). Ideally, ambient concentrations of primary particles could be linked to primary particle emissions by use of nanoparticle dispersion models, and secondary nanoparticles using photochemical modeling tools. The limitations in these areas are discussed. Although there is inadequate information on the exact biological mechanism through which these particles cause harm, it is argued that this should not in itself delay the introduction of regulation. This article reviews the missing links between the existing knowledge of nanoparticle number concentrations and the advances required to tackle the technical challenges implied in developing regulations. Recent Euro 5 and Euro 6 vehicle emission standards are the first ever initiative to control particles on a number basis at the source. Related standards are also desirable for ambient nanoparticles (taken in this article to be those below 300 rim) to protect against possible adverse effects on public health and the environment. However, there are a number of technical challenges that need to be tackled before developing a regulatory framework for atmospheric nanoparticles. Some of the challenges derive from a lack of standardisation of the key measurement parameters, including sampling, necessary for robust evaluation of particle number concentrations, especially in the context of insufficient knowledge of the physicochemical characteristics of emerging sources (i.e. bio-fuel derived and manufactured nanoparti- cles). Ideally, ambient concentrations of primary particles could be linked to primary particle emissions by use of nanoparticle dispersion models, and secondary nanoparticles using photochemical modeling tools. The limitations in these areas are discussed. Although there is inadequate information on the exact biological mechanism through which these particles cause harm, it is argued that this should not in itself delay the introduction of regulation. This article reviews the missing links between the existing knowledge of nanoparticle number concentrations and the advances required to tackle the technical challenges implied in developing regulations.
出处 《Particuology》 SCIE EI CAS CSCD 2011年第6期566-571,共6页 颗粒学报(英文版)
基金 an EPSRC grant(EP/H026290/1),awarded to PK,on nanoparticles dispersion invehicle wakes
  • 相关文献

参考文献59

  • 1LUC G, BARD J M, ARVEILER D, et al. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study[J]. Atherosclerosis,2001,163(2):377-384.
  • 2ERBAGCI A B, TARAKCIOGLU M, AKSOY M, et al. Diagnostic value of CRP and Lp(a) in coronary heart disease[J]. Acta Cardiol, 2002,57(3):197-204.
  • 3LUNDSTAM U, HERLITZ J, KARLSSON T, et al. Serum lipids, lipoprtein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease[J]. J Intern Med, 2002,251(2):111-118.
  • 4王青,胡大一,许玉韵.氧化修饰低密度脂蛋白、脂蛋白(a)和血脂指标检测对冠心病预测价值的比较[J].中国医刊,2002,37(1):23-25. 被引量:3
  • 5Brouwer, D. (2010). Exposure to manufactured nanoparticles in different work places. Toxicology, 269, 120-127.
  • 6CLEEMAN J I. Executive summary of the third report of the national cholesterol education program(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(adults treatment Panel III)[J]. JAMA,2001,285(13):2486-2497.
  • 7SORRENTINO M J. Cholesterol reduction to prevent CAD: what do the data show?[J]. Postgraduate Med, 2000(3):108:40-56.
  • 8COUGHLAN B J, SORRENTIO M J. Does hypertriglyceridemia increase the risk of CAD?[J]. Post Graduate Med, 2001,108(2):77-84.
  • 9Charron, A., & Harrison, R. M. (2003). Primary particle formation from vehicle emissions during exhaust dilution in the road side atmosphere. Atmospheric Environment, 37, 4109-4119.
  • 10Cbeng, C. H., Cheung, C. S., Char, T. L., Lee, S. C., Yao, C. D., & Tsang, K. S. (2008). Corn parison of emissions of a direct injection diesel engine operating on biodiesel with emulsified and fumigated methanol. Fuel, 87(10-11 ), 1870-1879.

二级参考文献3

共引文献2

同被引文献4

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部